Navigation Links
Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation
Date:7/14/2014

ensive experience in successfully identifying and bringing oncology treatments to the clinic while Senior Vice President of Research at Cephalon, Inc. (acquired by TEVA Pharmaceuticals). Its Board of Directors includes senior executives in the pharmaceutical industry, with deep mergers and acquisitions (M&A) experience.
  • The company is expected to have steady news flow. Interim Phase II data are expected to be announced at the Apple Congress on Saturday, July 12, 2014. Positive interim data should positively impact the GNSZ stock price. Additionally, in the third quarter the company should initiate Phase II clinical trial in renal cell carcinoma, and in the first quarter of 2015 GenSpera expects to present interim data for ongoing glioblastoma trial.
  • Based on the company's attractive growth prospects with a pipeline of products based upon its unique platform targeting large tumor applications; and strong development and experienced management team that has taken drugs successfully through clinical trials, we recommend the purchase of GNSZ stock for speculative accounts seeking long-term capital appreciation. Our target: more than a double within the next 12-24 months.
  • About GenSpera
    GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. Unlike typical chemotherapeutic agents, thapsigargin results in cell death irrespective of the rate of cell division, which may provide an effective approach to kill both fast- and slow-growing cancers. GenSpera's lead drug candidate, G-202, is activated by the enzyme PSMA, which is found at high levels in the vasculature of liver and glioblastoma cancers and in the vasculature of almost all other solid tumors. G-202 is therefore expected to have potential efficacy in a wide variety of tumor types.

    G-202 Phase II clinical trials are underway
    '/>"/>

    SOURCE GenSpera, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. CVS Caremark Corporation Announces Quarterly Dividend
    2. Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering
    3. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
    4. Volcano Corporation Announces Preliminary Fourth Quarter 2013 Revenues; Year-Over-Year Annual Revenues Increase Eight Percent On A Constant Currency Basis
    5. Novartis Pharmaceuticals Corporation stands behind medication adherence activities and reaffirms commitment to patient safety
    6. Heska Corporation to Present at the Sidoti Semi-Annual Micro-Cap Conference
    7. Ramon Martinez Named President of Comprehensive Care Corporation and Elected to the Companys Board of Directors
    8. Dynasil Corporation of America Reports Fiscal Year 2013 Financial Results
    9. Ormco Corporation Files Appeal to the Federal Court Against Ortho Classic H4 Bracket Patent Infringement
    10. EPGL Technology Selected by Major Corporation for Development
    11. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... , May 1, 2015  Thoratec Corporation (NASDAQ: ... to save, support and restore failing hearts, announced today that ... created role of President, International. This new ... commercial operations outside of North America , ... , and Latin America , and reports ...
    (Date:5/1/2015)... Calif. , May 1, 2015 The ... its 2015 health literacy award winners. The IHA Health ... that make an impact on the practice of educating ... health literacy. IHA gives awards in three categories: innovative ... bestowed its Health Literacy Hero award. In ...
    (Date:5/1/2015)... , May 1, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets products that assist ... today reported financial results for the first quarter ended ... quarter of 2015, Semler reported continued progress with year ... quarter revenue growth of 14%," said Doug Murphy-Chutorian ...
    Breaking Medicine Technology:Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5
    (Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch as ... and coolest technology products available to consumers. Scott Steinberg, a ... and shared with viewers how to protect their private information. ... on computers and even more so online. It helps everyone ... over the world. In terms of work, the internet makes ...
    (Date:5/3/2015)... is not too late to register to take part in the ... Been in Arnold, Missouri on May 9, 2015. Family and ... loving memory. It has benefited the renowned Brain Aneurysm Foundation each ... suffered a brain aneurysm . After two operations and five ... designed to serve as a remembrance of her and to help ...
    (Date:5/2/2015)... Vancouver fencing company, QS Fencing, has recently announced ... prospective clients related to their questions on railings and gates. ... their decks and patios. While that seems like an easy ... the person rolls up their sleeve to start working. One ... finding a gate that matches it. , Instead of spending ...
    (Date:5/2/2015)... We are pleased to announce the Sun ... one of the Top Workplaces of 2015. , The ... field for their ethics and standards of excellence. The ... their educational efforts. The Delray Recovery Center prides itself ... purpose – to help individuals heal from the disease ...
    (Date:5/2/2015)... As a nonsurgical staple in ... face, neck and décolleté, radiofrequency energy is proving ... for the success of vulvovaginal rejuvenation. In a ... Council, ThermiGyn’s Women’s Health Clinical Advisory Board Chairman ... ThermiGyn’s temperature controlled radio frequency, specifically that of ...
    Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3
    ... 12 Tennessee-based,Shared Health, Inc., the largest ... announced today the results of a new ... following implementation of its HIE. The,efficiency improvements ... when incorporating the Shared Health solution into ...
    ... Dermatologist Doing His Part to Warn Consumers, OMAHA, ... has been in the news for the past several ... Fig, the,parent company for up to 18 facilities around ... procedure, has closed its stores and is,considering declaring bankruptcy. ...
    ... as Chairman of the Board, LIVINGSTON, N.J., Dec. ... recognized leader in,advanced injection technologies, today announced that the ... of the Company,s,medical division, as the new CEO of ... effective January 1, 2008. As CEO, Martin replaces Leonard,Osser, ...
    ... drug has been shown to improve the sleep quality ... the most commonly-used medication, according to research published today ... compared the effects of the new drug dexmedetomidine with ... the pain and anxiety experienced by mechanically ventilated ICU ...
    ... A new development in the fight against cancer: Recent ... found in common fungus Ganoderma lucidum aid in suppressing ... prostate cancer. The main action of the fungus: disrupting ... cells. , Over the past 3-4 decades much ...
    ... Rispler-Chaim of the Department of Arabic language and literature ... to people with various disabilities based on Muslim jurists, ... era. , In the Islamic legal literature people with ... such as religious duties, jihad, marriage, etc., but seldom ...
    Cached Medicine News:Health News:New Data From Shared Health, Inc., Proves Effectiveness of Health Information Exchange for Improving Patient Outcomes at the Point of Care 2Health News:Will Lipodissolve Continue to Remain Popular? 2Health News:Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors 2Health News:Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors 3Health News:Intensive care quality of sleep improved by new drug, reports study 2Health News:Active compounds found in Ganoderma lucidum fungus with potential to treat prostate cancer 2
    SPIRAL-FLEX® Oral Precut Reinforced Tubes...
    Pre-Loaded with a Stylet., ,Available Cuffed or Uncuffed, pre-loaded with a stylet to facilitate quick intubations....
    ... cuff., ,Sheridan Endotracheal Tubes offer the ... level of tactile feedback from pilot balloon ... soften at body temperature , Smooth tube ... trauma during intubation , Two distinct cuff ...
    Adult (ICU) Tracheal Tubes with Micro-thin-walled cuffs....
    Medicine Products: